A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer

Clinical Oncology

Volumn 24, Issue 10, 2012, Pages 697-706

  Spooner, D ^a   Stocken, D D ^b   Jordan, S ^b   Bathers, S ^b   Dunn, J A ^c   Jevons, C ^b   Dodson, L ^a   Morrison, J M ^a   Oates, G D ^a   Grieve, R J ^d  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

Early breast cancer; Optimal fractionation; Radiotherapy; Randomised controlled trial

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SALVAGE THERAPY;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CONFIDENCE INTERVALS; DISEASE MANAGEMENT; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY DOSAGE; TREATMENT OUTCOME;

EID: 84868300341     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.08.003     Document Type: Article

References (31)

1. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 1996, 348:708-713.
2. Blamey R.W., Chetty U., Mitchell A. The BASO II trial of adjuvant radiotherapy versus none and tamoxifen versus none in small, node negative, grade I tumours [abstract 413]. Eur J Cancer 2002, 38(Suppl. 3):S149. on behalf of the British Association of Surgical Oncology (BASO) Breast Group.
3. Montgomery A.C., Greening W.P., Levene A.L. Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy. J R Soc Med 1978, 71(5):339-342.
4. Freeman C.R., Belliveau N.J., Kim T.H., et al. Limited surgery with or without radiotherapy for early breast carcinoma. J Can Assoc Radiol 1981, 32:125-128.
5. Overgaard M., Bentzen S.M., Christensen J.J., et al. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 1987, 9:1-11.
6. Clark R.M., Wilkinson R.H., Mahoney L.J., et al. Breast cancer: a 21 year experience with conservative surgery and radiation. Int J Radiat Oncol Biol Phys 1982, 8(6):967-979.
7. Allison P.D. Survival analysis using the SAS system 1995, SAS Institute, Cary, NC.
8. Yarnold J. Early and locally advanced breast cancer: diagnosis and treatment. Clin Oncol 2009, 21:159-160. National Institute for Health and Clinical Excellence Guide 2009.
9. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347(16):1233-1241.
10. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 1995, 333(22):1444-1455. Early Breast Cancer Trialists' Collaborative Group.
11. Clark M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366(9503):2087-2106.
12. R. Peto, for the Early Breast Cancer Trialists' Collaborative Group. The worldwide overview: new results for systemic adjuvant therapies. Presentation at the 30th Annual San Antonia Breast Cancer Symposium, 13-16 December 2007 San Antonio, TX.
13. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 2002, 94:1143-1150.
14. The S.T.A.R.T. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9:331-341. Trialists Group.
15. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371:1098-1107. The START Trialists Group.
16. Fourquet A., Campana F., Zafrani B., et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989, 17(4):719-725.
17. Kurtz J.M., Amalric R., Brandone H., et al. Local recurrence after breast conserving surgery and radiotherapy. Frequency, time course and prognosis. Cancer 1989, 63:1912.
18. Gage I., Recht A., Gelman R., et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995, 33(2):245-251.
19. Smith T.E., Lee D., Turner B.C., et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000, 48:1281.
20. Improving outcomes in breast cancer 2002, National Institute for Health and Clinical Excellence (NICE), Cancer Service Guidance, NICE, London.
21. Early and locally advanced breast cancer: diagnosis and treatment 2009, National Institute for Health and Clinical Excellence (NICE), NICE, London.
22. Lilegren G., Holmberg L., Adami H.O., et al. Sector resection with or without postoperative radiotherapy for stage-I breast cancer - 5-year results of a randomized trial. J Natl Cancer Inst 1994, 86:717-722.
23. Veronesi U., Luini A., Del Vecchio M., et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993, 328:1587-1591.
24. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst 1996, 88:1659-1664.
25. Renton S.C., Gazet J.C., Ford H.T., et al. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol 1996, 22:17-22.
26. Malmstrom P., Holmberg L., Anderson H., et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 2003, 39:1690-1697.
27. Potter R., Gnant M., Kwasny W., et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 2007, 68:334-340.
28. Warner E., Chow E., Fairchild A., Franssen E., Paszat L., Szumacher E. Attitudes of Canadian radiation oncologists towards post-lumpectomy radiotherapy for elderly women with stage I hormone-responsive breast cancer. Clin Oncol 2010, 22:97-106.
29. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006, 7:467-471.
30. Vicini F.A., Kestin L., Chen P., et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003, 95:1205-1210.
31. Benitez P.R., Keisch M.E., Vicini F., et al. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007, 194:456-462.